Reuters logo
BRIEF-Hebei Changshan Biochemical Pharmaceutical sees Q1 to Q3 of FY 2017 net profit up 30 pct to 40 pct
October 9, 2017 / 3:19 AM / 12 days ago

BRIEF-Hebei Changshan Biochemical Pharmaceutical sees Q1 to Q3 of FY 2017 net profit up 30 pct to 40 pct

Oct 9 (Reuters) - Hebei Changshan Biochemical Pharmaceutical Co Ltd

* Sees net profit for FY2017 Q1 to Q3 to increase 30 percent to 40 percent, or to be 130.4 million yuan to 140.5 million yuan

* Says the net profit of FY2016 Q1 to Q3 was 100.3 million yuan

* Comments that increased drug price is the main reason for the forecast

Source text in Chinese:goo.gl/d6q42N

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below